Clinical trial

Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)

NCT02014363

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention ETS6103 (low dose) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention ETS6103 (high dose) Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Amitriptyline Normalized identity: amitriptylineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-10-01

PhasePHASE2

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

ETS6103 (low dose)DRUG

ETS6103 (high dose)DRUG

AmitriptylineDRUG · verified · RxNorm: amitriptyline

Sponsors & collaborators

e-Therapeutics PLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02014363 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.